The global renal denervation systems market is poised to witness a steady growth during the forecast period. This is expected to be driven by major factors such as rising prevalence of hypertension, increasing geriatric population, clinical advantages such as fast recovery time with minimal complications, technological advancements to develop alternative technologies. Moreover, increasing clinical trials to validate clinical efficacy of renal denervation and cost effectiveness of the procedure over conventional surgeries are expected to offer high growth opportunities for players active in the global renal denervation systems market.

However, stringent regulatory guidelines for product approval in specific countries are expected to hamper the optimal market growth for renal denervation systems during the forecast period.

As of 2016, Medtronic, Plc. Boston Scientific Corporation, St. Jude Medical, Inc., ReCor Medical, Inc., Cordis Corporation, and Terumo Corporation are some of the key players present in global renal denervation systems market. Over the past three years, these companies adopted new product development and launches, collaborations, agreements, partnerships, and geographical expansions as their key business strategies to ensure their growth in this market.

Scope of the Report

This research report categorizes renal denervation systems market into the following segments and subsegments: